SUMO--a post-translational modification with therapeutic potential?
about
Novel mechanisms of endothelial mechanotransductionSmall-molecule activation of SERCA2a SUMOylation for the treatment of heart failure.The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosisSUMO3 modification accelerates the aggregation of ALS-linked SOD1 mutants.SUMOylation represses Nanog expression via modulating transcription factors Oct4 and Sox2HDAC4 degradation mediates HDAC inhibition-induced protective effects against hypoxia/reoxygenation injury.ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.Reactive Oxygen Species, SUMOylation, and Endothelial InflammationAltered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responsesDisturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events.Flow signaling and atherosclerosis.Determination of SUMO1 and ATP affinity for the SUMO E1by quantitative FRET technology.Comprehensive list of SUMO targets in Caenorhabditis elegans and its implication for evolutionary conservation of SUMO signaling.Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation
P2860
Q27022880-8E2259D5-9D5C-4D95-9048-7D80C47B7AF5Q30654383-5D941B16-3A2D-44AA-A8AF-9C4C4D7E090EQ33770904-9E1DA700-CA53-40B2-86E8-B58A5F73AC60Q33817594-2B43419D-B340-4223-8F4D-21609DB95FD6Q34321578-0860714D-6FF3-444E-A6B3-01D81F15B314Q35216855-6E5837FC-E3D5-4200-862C-EF4EA7B4F022Q35629054-4C324BB2-E95F-4DFC-89DE-0576E5A6888DQ36237663-82705CEC-1C9F-494B-A4AD-50F74DEA56B1Q36837270-052B18F1-BA18-4EFF-B98F-E11E1E65EF6FQ36881822-2325DDD7-FC9E-42FA-BF08-9BAEE63CEF2CQ38926909-DC8CE96D-8AED-4CCF-A8FC-4B95264AA18FQ39063397-CBCDFF61-82FB-4F29-8E77-3D2DE5255593Q46765579-EE6CA8FC-8934-434A-9BC2-B9FA2EA86A7BQ49203409-7948EC60-9D59-4A81-B2A9-89D27DDFE6C5Q58761411-F2097170-9EEB-4521-9848-163968EA9168
P2860
SUMO--a post-translational modification with therapeutic potential?
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
SUMO--a post-translational modification with therapeutic potential?
@ast
SUMO--a post-translational modification with therapeutic potential?
@en
SUMO--a post-translational modification with therapeutic potential?
@nl
type
label
SUMO--a post-translational modification with therapeutic potential?
@ast
SUMO--a post-translational modification with therapeutic potential?
@en
SUMO--a post-translational modification with therapeutic potential?
@nl
prefLabel
SUMO--a post-translational modification with therapeutic potential?
@ast
SUMO--a post-translational modification with therapeutic potential?
@en
SUMO--a post-translational modification with therapeutic potential?
@nl
P2860
P1476
SUMO--a post-translational modification with therapeutic potential?
@en
P2093
Chang-Hoon Woo
Jun-Ichi Abe
P2860
P304
P356
10.1016/J.COPH.2009.12.001
P577
2010-01-14T00:00:00Z